KAMILAH TOURNER-NICHOLS: Open Payments
NPI 1295450153 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$614 in 33 payments from 13 companies in 2025. Trend: 2023 $814 · 2024 $798 · 2025 $614
Food & beverage: $614
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $110 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $72 |
| PFIZER INC. | 4 | $65 |
| BridgeBio Pharma, Inc. | 3 | $58 |
| Alnylam Pharmaceuticals Inc. | 2 | $55 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
| Actelion Pharmaceuticals US, Inc. | 2 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
Products named: LifeVest, Kerendia, VYNDAQEL, Wegovy, Attruby, AMVUTTRA, Ozempic, VERQUVO.
Industry payments across IN — which companies pay providers there.
